ImpediMed
(OTC) IPDQF
ImpediMed Financials at a Glance
Market Cap
$18.19M
Revenue (TTM)
A$25.77M
Net Income (TTM)
-A$45.59M
EPS (TTM)
-$0.01
P/E Ratio
-0.65
Dividend
$0.00
Beta (Volatility)
0.31 (Low)
Dividend
$0.00
Beta (Volatility)
0.31 (Low)
Price
$0.01
Volume
202,000
Open
$0.01
Price
$0.01
Volume
202,000
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.05
Estimated Earnings Date
Aug 27, 2026
Dividend
$0.00
Beta (Volatility)
0.31 (Low)
Price
$0.01
Volume
202,000
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.05
Estimated Earnings Date
Aug 27, 2026
IPDQF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout ImpediMed
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
77
CEO
Parmjot Bains, PhD
Website
www.impedimed.comHeadquarters
Pinkenba, QLD 4008, AU
IPDQF Financials
Key Financial Metrics (TTM)
Gross Margin
-5.85%
Operating Margin
-156.48%
Net Income Margin
-171.25%
Return on Equity
-165.13%
Return on Capital
-69.26%
Return on Assets
-63.53%
Earnings Yield
-1.54%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$18.19M
Shares Outstanding
3.66B
Volume
202.00K
Avg. Volume
11.85K
Financials (TTM)
Gross Profit
A$9.31M
Operating Income
-A$23.31M
EBITDA
-A$35.89M
Operating Cash Flow
-A$35.16M
Capital Expenditure
A$6.57M
Free Cash Flow
-A$28.59M
Cash & ST Invst.
A$18.84M
Total Debt
A$21.93M
ImpediMed Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
A$7.51M
+57.0%
Gross Profit
-A$6.51M
+16.8%
Gross Margin
-86.70%
N/A
Market Cap
$18.19M
N/A
Market Cap/Employee
$219.15K
N/A
Employees
83
N/A
Net Income
-A$12.28M
-26.3%
EBITDA
-A$7.50M
-41.7%
Quarterly Fundamentals
Total Cash
A$18.84M
-49.0%
Total Debt
A$21.93M
+1622.3%
Accounts Receivable
A$3.75M
+86.8%
Inventory
A$2.27M
+152.1%
Long Term Debt
A$21.62M
+2145.3%
Short Term Debt
A$302.88K
-2.3%
Return on Assets
-63.53%
N/A
Return on Invested Capital
-70.68%
N/A
Free Cash Flow
A$0.00
+100.0%
Operating Cash Flow
-A$9.50M
-40.2%